Inventor · disambiguated record
Magnus Brisander
Also filed as: BRISANDER MAGNUS
22 granted patents·8 pending applications·393 citations·filing 2011–2024
97Inventor score
Files withXSPRAY MICROPARTICLES AB13XSPRAY PHARMA AB11ASARINA PHARMA AB3BISRAT MIKAEL2CERBIOS PHARMA SA1
Top patents by PatentIndex Score
30 records- 0198US11241419B2Pharmaceutical compositionsXSPRAY PHARMA AB·Filed 2020·Granted Feb 8, 2022·7 cites·24 claims
- 0298US10772877B2Pharmaceutical compositionsXSPRAY MICROPARTICLES AB·Filed 2020·Granted Sep 15, 2020·21 cites·30 claims
- 0398US10314830B2Pharmaceutical compositionsXSPRAY MICROPARTICLES AB·Filed 2018·Granted Jun 11, 2019·38 cites·30 claims
- 0498US10143683B2Pharmaceutical compositionsXSPRAY MICROPARTICLES AB·Filed 2017·Granted Dec 4, 2018·39 cites·30 claims
- 0598US9833442B2Pharmaceutical compositionsXSPRAY MICROPARTICLES AB·Filed 2017·Granted Dec 5, 2017·41 cites·23 claims
- 0698US9833443B2Pharmaceutical compositionsXSPRAY MICROPARTICLES AB·Filed 2017·Granted Dec 5, 2017·34 cites·23 claims
- 0798US9827230B2Pharmaceutical compositionsXSPRAY MICROPARTICLES AB·Filed 2016·Granted Nov 28, 2017·41 cites·23 claims
- 0898US9456992B2Pharmaceutical composition comprising stable, amorphous, hybrid nanoparticles of at least one protein kinase inhibitor and at least one polymeric stabilizing and matrix forming componentXSPRAY MICROPARTICLES AB·Filed 2013·Granted Oct 4, 2016·63 cites·55 claims
- 0997US11517562B2Pharmaceutical compositionsXSPRAY PHARMA AB·Filed 2022·Granted Dec 6, 2022·3 cites·30 claims
- 1097US11426391B2Pharmaceutical compositionsXSPRAY PHARMA AB·Filed 2022·Granted Aug 30, 2022·3 cites·30 claims
- 1197US11376243B2Pharmaceutical compositionsXSPRAY PHARMA AB·Filed 2022·Granted Jul 5, 2022·4 cites·30 claims
- 1297US10561643B2Pharmaceutical compositionsXSPRAY MICROPARTICLES AB·Filed 2019·Granted Feb 18, 2020·20 cites·27 claims
- 1397US10561645B2Pharmaceutical compositionsXSPRAY MICROPARTICLES AB·Filed 2019·Granted Feb 18, 2020·20 cites·18 claims
- 1497US10561644B2Pharmaceutical compositionsXSPRAY MICROPARTICLES AB·Filed 2019·Granted Feb 18, 2020·20 cites·29 claims
- 1597US10555937B2Pharmaceutical compositionsXSPRAY MICROPARTICLES AB·Filed 2019·Granted Feb 11, 2020·20 cites·29 claims
- 1697US10314829B2Pharmaceutical compositionsXSPRAY MICROPARTICLES AB·Filed 2018·Granted Jun 11, 2019·19 cites·30 claims
- 1793US12144804B1Pharmaceutical compositionsXSPRAY PHARMA AB·Filed 2024·Granted Nov 19, 2024·0 cites·30 claims
- 1893US2024398769A1Pharmaceutical compositionsXSPRAY PHARMA AB·Filed 2024·Application pending·0 cites
- 1991US12076314B2Pharmaceutical compositionsXSPRAY PHARMA AB·Filed 2024·Granted Sep 3, 2024·0 cites·30 claims
- 2083US11963951B2Pharmaceutical compositionsXSPRAY PHARMA AB·Filed 2021·Granted Apr 23, 2024·0 cites·23 claims
- 2173US2025041206A1Injectable SuspensionsASARINA PHARMA AB·Filed 2024·Application pending·0 cites
- 2266US2016250153A1Novel methodsXSPRAY MICROPARTICLES AB·Filed 2016·Application pending·0 cites
- 2365US10933014B2Injectable suspension comprising 3-beta-hydroxy-5-alpha-pregnan-20-one, and a method for the manufacturing thereofASARINA PHARMA AB·Filed 2018·Granted Mar 2, 2021·0 cites·9 claims
- 2465US2024024248A1Fast dissolving pharmaceutical compositionsXSPRAY PHARMA AB·Filed 2023·Application pending·0 cites
- 2562US2023121325A1Fast dissolving pharmaceutical compositionsXSPRAY PHARMA AB·Filed 2022·Application pending·0 cites
- 2660US2021100736A1Injectable SuspensionsASARINA PHARMA AB·Filed 2020·Application pending·0 cites
- 2759US11529351B2Fast dissolving pharmaceutical compositionsXSPRAY PHARMA AB·Filed 2022·Granted Dec 20, 2022·0 cites·17 claims
- 2851US2015231120A1Tiotropium preparationsCERBIOS PHARMA SA·Filed 2013·Application pending·0 cites
- 2940US9314525B2Picropodophyllin polymorph C and its use in cancer therapyBISRAT MIKAEL·Filed 2011·Granted Apr 19, 2016·0 cites·20 claims
- 3031US2013331445A1Picropodophyllin Monohydrate or Polymorph A in Cancer TherapyBISRAT MIKAEL·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Magnus Brisander files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →